Vineti nets $13.75 mln Series A
Vineti, a cloud-based platform to expand patient access to life-saving cell and gene therapies, has secured $13.75 million in Series A funding. The investors were GE Ventures, Mayo Clinic Ventures, DFJ and LifeForce Capital.
23 June 2017•1 min read
